Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Merck & Co | MRK | 15. nov 2024 | 96.31 | -2.08 |
Mercurity Fintech | MFH | 15. nov 2024 | 3.78 | +5.88 |
Mercury General | MCY | 15. nov 2024 | 73.00 | -0.55 |
Mercury Systems | MRCY | 15. nov 2024 | 39.32 | -3.72 |
Mereo BioPharma ADR | MREO | 15. nov 2024 | 3.53 | -7.59 |
Meridian | MRBK | 15. nov 2024 | 14.23 | +0.57 |
MeridianLink | MLNK | 15. nov 2024 | 22.02 | -3.00 |
Merit Medical Systems | MMSI | 15. nov 2024 | 101.83 | +0.62 |
Meritage Homes | MTH | 15. nov 2024 | 179.41 | -1.00 |
Merrill Lynch & Co. | IPB | 15. nov 2024 | 26.20 | +0.38 |
Mersana Therapeutics | MRSN | 15. nov 2024 | 2.21 | -12.30 |
Merus N.V | MRUS | 15. nov 2024 | 46.58 | -6.20 |
Mesa Air Group | MESA | 15. nov 2024 | 0.86 | -2.42 |
Mesa Laboratories | MLAB | 15. nov 2024 | 102.44 | -2.07 |
Mesa Royalty Trust | MTR | 15. nov 2024 | 6.25 | +6.47 |
Mesabi Royalty Trust | MSB | 15. nov 2024 | 25.51 | -1.16 |
Mesoblast ADR | MESO | 15. nov 2024 | 10.04 | -11.31 |
Meta Materials | MMAT | 15. nov 2024 | 0.64 | 0.00 |
Meta Platforms A | META | 15. nov 2024 | 554.08 | -4.00 |
Metagenomi | MGX | 15. nov 2024 | 1.82 | -3.19 |
Metal Sky Star Acquisition | MSSA | 15. nov 2024 | 12.00 | 0.00 |
Metalla Royalty & Streaming | MTA | 15. nov 2024 | 2.85 | -7.17 |
Metallus | MTUS | 15. nov 2024 | 14.49 | -2.03 |
Metals Acquisition | MTAL | 15. nov 2024 | 11.65 | -3.40 |
Methalpa Technology Holding | MATH | 15. nov 2024 | 1.00 | -11.16 |
Methanex | MEOH | 15. nov 2024 | 42.64 | -0.49 |
Methode Electronics | MEI | 15. nov 2024 | 9.30 | -4.32 |
MetLife | MET | 15. nov 2024 | 83.33 | +0.88 |
Metlife Pref A | MET-A | 15. nov 2024 | 24.54 | +0.08 |
Metlife Pref E | MET-E | 15. nov 2024 | 24.53 | +0.25 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.